SCHEMBL3467553

SCHEMBL3467553

CC(C)(C)OC(=O)CBr.N#Cc1ccc2c(ccn2CC(=O)O)c1

nearest known ligand 0.43

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 4/20 0.41
ALDH1A1 P00352 4/20 0.41
TSHR P16473 3/20 0.41
HSD17B10 Q99714 3/20 0.41
HPGD P15428 2/20 0.41
GLA P06280 1/20 0.41
HTT P42858 1/20 0.41
NPY5R Q15761 1/20 0.41
KMT2A Q03164 1/20 0.40
PPARD Q03181 7/20 0.40
PPARA Q07869 6/20 0.40
FFAR4 Q5NUL3 1/20 0.40
PPARG P37231 3/20 0.39
USP2 O75604 1/20 0.38
POLB P06746 1/20 0.38
ABCB1 P08183 1/20 0.37
P2RX7 Q99572 1/20 0.36
PLA2G4A P47712 1/20 0.36
PRMT5 O14744 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27844158 0.88 NPY5R (0.45) KDM4EALDH1A1TSHRHSD17B10HPGD
SCHEMBL3465527 0.84 KMT2A (0.55) KDM4EALDH1A1TSHRHSD17B10HPGD
SCHEMBL2487330 0.81 FFAR4 (0.36) NPY5RFFAR4ABCB1
SCHEMBL8029435 0.77 ATM (0.53) KDM4EALDH1A1TSHRHSD17B10HPGD
SCHEMBL2470686 0.75 MAPT (0.48) KDM4EALDH1A1TSHRHSD17B10HPGD
SCHEMBL9009161 0.74 MTNR1A (0.47) KDM4EALDH1A1TSHRHSD17B10HPGD
SCHEMBL14632407 0.74 ALDH1A1 (0.65) KDM4EALDH1A1TSHRHSD17B10HPGD
SCHEMBL1435781 0.72 NPY5R (0.42) KDM4EALDH1A1TSHRHSD17B10HPGD
SCHEMBL1435785 0.72 NPY5R (0.42) KDM4EALDH1A1TSHRHSD17B10HPGD
SCHEMBL2951656 0.72 DRD2 (0.40) KDM4EALDH1A1TSHRHSD17B10HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010069949-A1 OXADIAZOLE FUSED HETEROCYCLIC DERIVATIVES USEFUL FOR THE TREATMENT OF MULTIPLE SCLEROSIS MERCK SERONO S.A. (CH) 2010-06-24 WO disclosed